WallStreetZenWallStreetZen

NASDAQ: DRRX
Durect Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their DRRX stock forecasts and price targets.

Forecast return on equity

Is DRRX forecast to generate an efficient return?

Company
2,737.19%
Industry
30.83%
Market
-47.44%
DRRX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is DRRX forecast to generate an efficient return on assets?

Company
763.79%
Industry
14.66%
DRRX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

DRRX earnings per share forecast

What is DRRX's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.66
Avg 2 year Forecast
-$0.70

DRRX revenue forecast

What is DRRX's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$1.2M
Avg 2 year Forecast
$1.0M
Avg 3 year Forecast
$39.5M

DRRX vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
DRRX$1.90N/AN/A
BGM$8.15N/AN/A
KALA$8.58$13.50+57.34%Buy
QNTM$20.62N/AN/A
CPIX$3.07N/AN/A
View Top Pharmaceutical Stocks

Durect Stock Forecast FAQ

What is DRRX's earnings growth forecast for 2025-2026?

(NASDAQ: DRRX) Durect's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 24.04%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.24%.

Durect's earnings in 2025 is -$3,478,000.On average, 1 Wall Street analyst forecast DRRX's earnings for 2025 to be -$20,495,763, with the lowest DRRX earnings forecast at -$20,495,763, and the highest DRRX earnings forecast at -$20,495,763.

In 2026, DRRX is forecast to generate -$21,737,931 in earnings, with the lowest earnings forecast at -$21,737,931 and the highest earnings forecast at -$21,737,931.

If you're new to stock investing, here's how to buy Durect stock.

What is DRRX's revenue growth forecast for 2025-2027?

(NASDAQ: DRRX) Durect's forecast annual revenue growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.28%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.94%.

Durect's revenue in 2025 is -$1,199,000.On average, 1 Wall Street analysts forecast DRRX's revenue for 2025 to be $36,954,483, with the lowest DRRX revenue forecast at $36,954,483, and the highest DRRX revenue forecast at $36,954,483. On average, 1 Wall Street analysts forecast DRRX's revenue for 2026 to be $31,054,187, with the lowest DRRX revenue forecast at $31,054,187, and the highest DRRX revenue forecast at $31,054,187.

In 2027, DRRX is forecast to generate $1,226,950,928 in revenue, with the lowest revenue forecast at $1,226,950,928 and the highest revenue forecast at $1,226,950,928.

What is DRRX's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: DRRX) forecast ROA is 763.79%, which is higher than the forecast US Drug Manufacturers - Specialty & Generic industry average of 14.66%.

What is DRRX's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: DRRX) Durect's current Earnings Per Share (EPS) is -$0.10. On average, analysts forecast that DRRX's EPS will be -$0.66 for 2025, with the lowest EPS forecast at -$0.66, and the highest EPS forecast at -$0.66. In 2026, DRRX's EPS is forecast to hit -$0.70 (min: -$0.70, max: -$0.70).

What is DRRX's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: DRRX) forecast ROE is 2,737.19%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.